VRAY - ビュ―レイ （ViewRay Inc.） ビュ―レイVRAYのチャート
VRAYの企業情報
| symbol | VRAY |
|---|---|
| 会社名 | ViewRay Inc （ビュ―レイ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 ビューレー(ViewRay Inc.)はがん患者のイメージングと治療を同時に行う磁気共鳴イメージング（MRI）誘導放射線治療システムであるMRIdianを設計・製造・販売する。MRIdianは、MRI技術、放射線送達およびそのソフトウェアを統合して、放射線が送達されている間に軟部組織腫瘍の位置・形状を見つけ、標的にし、追跡する。MRIdianはまた、治療領域が受けた放射線量のレベルを記録し、医師が必要に応じて治療間で処方を適合させることを可能にする。同社はMRIdianを、大学の研究および教育病院、地域病院、私立診療所、政府機関、自立した癌センターなど、多数の顧客に販売する。また、MRIdian Linacと呼ばれるMRIdian技術のリニアアクセラレータ、またはリニアックバージョンの開発に従事する。 ビュ―レイは米国の医療機器メ―カ―。同社と全額出資子会社ビュ―レイ・テクノロジ―ズは、MRI画像に導かれた放射線治療システム機器「MRIdian」の開発・製造・販売に従事。がん腫瘍をMRI画像で特定すると同時に放射線治療を行うため、周囲の臓器や細胞に与える負担を軽減することができる。本社はオハイオ州オ―クウッドビレッジ。 ViewRay, Inc., designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc. |
| 本社所在地 | 2 Thermo Fisher Way Oakwood Village OH 44146 USA |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | +1 440-703-3210 |
| 設立年月日 | 41518 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 139人 |
| url | www.viewray.com |
| nasdaq_url | https://www.nasdaq.com/symbol/vray |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -51.22900 |
| 終値（lastsale） | 9.225 |
| 時価総額（marketcap） | 865815742.125 |
| 時価総額 | 時価総額（百万ドル） 794.01640 |
| 売上高 | 売上高（百万ドル） 74.75000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 772.47240 |
| 当期純利益 | 当期純利益（百万ドル） -65.39400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Viewray Inc revenues increased from $1.9M to $42.6M. Net loss applicable to common stockholders decreased 19% to $29.5M. Revenues reflect Product increase from $0K to $40.7M. Lower net loss reflects Other income (expense) net increase from $9.1M (expense) to $6.5M (income) Interest income increase of 100% to $4K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.69 to -$0.40. |
VRAYのテクニカル分析
VRAYのニュース
Jefferies downgrades ViewRay Inc to Hold 2023/04/17 07:36:37 Investing.com
https://www.investing.com/news/pro/viewray-inc-receives-investment-bank-analyst-rating-update-3056562
ViewRay extends losses as Street downgrades after guidance cut 2023/04/14 12:26:06 Seeking Alpha
ViewRay (VRAY) shares extended losses Friday as three analysts downgraded the stock after the MedTech company slashed its 2023 outlook. Read more here.
Stifel downgrades ViewRay Inc to Hold 2023/04/14 07:17:37 Investing.com
https://www.investing.com/news/pro/viewray-inc-receives-investment-bank-analyst-rating-update-3055452
ViewRay: Shares Crater As Company Warns Of Slower Growth, Higher Cash Burn 2023/04/13 23:28:13 Seeking Alpha
ViewRay, Inc. has shocked investors with a severe revenue and cash flow warning. VRAY now expects much lower 2023 revenue growth. Click here for our take on VRAY.
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday''s Mid-Day Session 2023/04/13 16:24:13 Benzinga
Gainers CXApp Inc. (NASDAQ: CXAI ) jumped 105% to $3.28 after climbing over 20% on Wednesday. SAB Biotherapeutics, Inc. (NASDAQ: SABS ) gained 71% to $0.6587 after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza. Auddia Inc. (NASDAQ: AUUD ) jumped 68.2% to $0.8917 after gaining more than 10% on Wednesday. Ocean Biomedical, Inc. (NASDAQ: OCEA ) jumped 50% to $6.76. Ocean Biomedical’s co-founder, Jonathan Kurtis, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. patent application covering a therapeutic and prophylactic monoclonal antibody that kills falciparum malaria parasites. Consolidated Communications Holdings, Inc. (NASDAQ: CNSL ) shares jumped 35.5% to $3.74 after Searchlight Capital and BCI submitted a non-binding proposal to acquire all outstanding shares of Consolidated Communications not owned by Searchlight or BCI for $4 per share.
Military University Hospital Prague Selects ViewRay''s MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients 2023/03/07 11:30:00 Benzinga
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER , March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic . This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic . The purchase was co-financed by the REACT-EU financial instrument and the founder''s contribution, the Ministry of Defense of the Czech Republic . The Military University Hospital Prague is a training, educational, and professional medical facility of the Army of the Czech Republic . It provides comprehensive health care at the level of teaching hospitals to members of the Czech Army, war veterans, and people in and outside the region.
Military University Hospital Prague Selects ViewRay''s MRIdian MRI-Guided Radiation Therapy System to Treat Cancer Patients 2023/03/07 11:30:00 PR Newswire
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER, March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced…
ViewRay Earnings Perspective: Return On Capital Employed 2023/03/02 14:49:45 Benzinga
Benzinga Pro data, ViewRay (NASDAQ: VRAY ) reported Q4 sales of $34.69 million. Earnings fell to a loss of $27.82 million, resulting in a 6.55% decrease from last quarter. In Q3, ViewRay brought in $26.49 million in sales but lost $26.11 million in earnings. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is … Full story available on Benzinga.com
ViewRay, Inc. 2023 Q4 - Results - Earnings Call Presentation (NASDAQ:VRAY) 2023/03/01 17:39:51 Seeking Alpha
The following slide deck was published by ViewRay, Inc.
ViewRay, Inc. (VRAY) Q4 2022 Earnings Call Transcript 2023/02/28 01:42:05 Seeking Alpha
ViewRay, Inc. (NASDAQ:NASDAQ:VRAY) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ETCompany ParticipantsMatt Harrison - Director of IRScott Drake - President and CEO Bill Burke…
Military University Hospital Prague Selects ViewRay''s MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients 2023/03/07 11:30:00 Benzinga
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER , March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic . This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic . The purchase was co-financed by the REACT-EU financial instrument and the founder''s contribution, the Ministry of Defense of the Czech Republic . The Military University Hospital Prague is a training, educational, and professional medical facility of the Army of the Czech Republic . It provides comprehensive health care at the level of teaching hospitals to members of the Czech Army, war veterans, and people in and outside the region.
Military University Hospital Prague Selects ViewRay''s MRIdian MRI-Guided Radiation Therapy System to Treat Cancer Patients 2023/03/07 11:30:00 PR Newswire
First and only MRIdian in the Czech Republic to bring advanced MRI-guided radiation therapy to the region DENVER, March 7, 2023 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech Ministry of Health has approved the purchase of ViewRay''s MRIdian system to bring advanced…
ViewRay Earnings Perspective: Return On Capital Employed 2023/03/02 14:49:45 Benzinga
Benzinga Pro data, ViewRay (NASDAQ: VRAY ) reported Q4 sales of $34.69 million. Earnings fell to a loss of $27.82 million, resulting in a 6.55% decrease from last quarter. In Q3, ViewRay brought in $26.49 million in sales but lost $26.11 million in earnings. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is … Full story available on Benzinga.com